VICTORIA LEICHT: Open Payments
NPI 1043596133 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $118 · 2025 $373
Food & beverage: $277Education: $96
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $96 |
| Novartis Pharmaceuticals Corporation | 4 | $69 |
| UCB, Inc. | 2 | $57 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| GENZYME CORPORATION | 1 | $28 |
| ABBVIE INC. | 1 | $25 |
| Verrica Pharmaceuticals Inc. | 1 | $22 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $20 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
Products named: DUPIXENT, COSENTYX, Bimzelx, Sotyktu, SKYRIZI, YCANTH, Cabtreo, Zoryve.
Industry payments across DE — which companies pay providers there.
